CACI insider reports 4,442 RSU/PRSU vestings and $515.16 sales
Rhea-AI Filing Summary
J. William Koegel Jr., EVP & General Counsel of CACI (CACI) reported multiple transactions dated 10/01/2025. The filing shows the vesting/acquisition of 4,442 common shares through restricted stock units and performance restricted stock units and the grant of 971 additional restricted stock units plus 971 performance restricted stock units. Concurrently, the report discloses dispositions of 2,101 common shares at $515.16 per share. After these transactions, Mr. Koegel beneficially owned 27,931 shares of CACI common stock, held directly.
Positive
- 4,442 shares vested from restricted stock units and performance restricted stock units on 10/01/2025
- New grants of 971 RSUs and 971 PRSUs were awarded on 10/01/2025, continuing long-term incentive alignment
Negative
- 2,101 shares disposed on 10/01/2025 at a price of $515.16 per share
- Net increase in reported transactions is larger in acquisitions than immediate holdings change, requiring attention to post-transaction holdings reporting
Insights
Insider reported routine equity vesting and partial sales on 10/01/2025.
The Form 4 records both vesting-related acquisitions and open-market dispositions by an executive officer. The pattern—vesting of RSUs/PRSUs and sales at a disclosed price—matches standard compensation liquidity actions.
This filing affects share count disclosure and transparency around insider liquidity; it does not by itself disclose changes to executive roles or company policy.
Material compensation events: vested RSUs/PRSUs and new grants on 10/01/2025.
The report shows 4,442 acquired shares from prior grants vesting and new grants of 971 RSUs and 971 PRSUs. The PRSUs vest based on a three-year performance measure; the RSUs vest 1/3 annually.
This documents the timing and structure of executive equity realization and ongoing incentive grants as disclosed in the filing.
FAQ
What transactions did the CACI insider report on Form 4 (CACI)?
How many shares does J. William Koegel Jr. beneficially own after the reported trades?
What are the terms for the reported performance restricted stock units (PRSUs)?
Do the restricted stock units (RSUs) have a vesting schedule?
At what price were shares disposed of in the filing?